Chen Huang Selected Research

Fallopian Tube Diseases

1/2022	Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube Recanalization.
1/2019	Combined chitosan and Dan-shen injection for long-term tubal patency in fallopian tube recanalization for infertility.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chen Huang Research Topics

Disease

158	Neoplasms (Cancer) 08/2022 - 04/2005
46	Stomach Neoplasms (Stomach Cancer) 06/2022 - 09/2004
37	Carcinogenesis 01/2022 - 04/2007
37	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2006
32	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2008
24	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 08/2005
22	Infections 02/2022 - 06/2005
19	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2013
14	Inflammation (Inflammations) 01/2022 - 04/2009
12	Colorectal Neoplasms (Colorectal Cancer) 04/2020 - 02/2003
11	Hypoxia (Hypoxemia) 01/2022 - 06/2007
11	Asthma (Bronchial Asthma) 01/2022 - 02/2013
10	Rhinitis 04/2022 - 02/2013
10	Fibrosis (Cirrhosis) 01/2019 - 11/2008
9	Colonic Neoplasms (Colon Cancer) 01/2020 - 10/2010
8	Carcinoma (Carcinomatosis) 11/2014 - 01/2006
7	Reperfusion Injury 10/2022 - 01/2012
7	Wounds and Injuries (Trauma) 04/2022 - 09/2010
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 07/2006
6	Nasopharyngeal Carcinoma 01/2022 - 11/2008
6	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2006
6	Glioma (Gliomas) 11/2021 - 08/2006
6	Sepsis (Septicemia) 10/2021 - 01/2018
6	Pain (Aches) 01/2021 - 12/2011
6	Squamous Cell Carcinoma of Head and Neck 01/2021 - 12/2012
6	Pneumonia (Pneumonitis) 01/2020 - 05/2012
6	Lymphatic Metastasis 01/2019 - 06/2007
5	Melanoma (Melanoma, Malignant) 03/2021 - 04/2013
5	Insulin Resistance 01/2021 - 02/2010
5	Hypernatremia 06/2020 - 08/2013
5	Adenocarcinoma 12/2019 - 06/2007
4	Myocardial Ischemia (Ischemic Heart Diseases) 10/2022 - 01/2017
4	Myocardial Infarction 01/2022 - 01/2008
4	Hypersensitivity (Allergy) 01/2022 - 02/2013
4	Residual Neoplasm 01/2022 - 01/2013
4	Ischemia 01/2022 - 09/2007
4	Necrosis 01/2021 - 01/2016
4	Esophageal Squamous Cell Carcinoma 01/2021 - 05/2007
4	Liver Neoplasms (Liver Cancer) 01/2021 - 12/2009
4	Disease Progression 01/2021 - 01/2018
4	Liver Diseases (Liver Disease) 10/2020 - 04/2016
4	Multiple Myeloma 09/2020 - 06/2012
4	Cross Infection (Nosocomial Infection) 06/2020 - 01/2018
4	Cataract (Cataracts) 03/2020 - 05/2013
4	Critical Illness (Critically Ill) 01/2020 - 11/2015
4	Hypertension (High Blood Pressure) 01/2020 - 02/2010
4	Eczema 01/2020 - 12/2016
4	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020 - 09/2016
4	Allergic Rhinitis 01/2020 - 07/2016
4	Stroke (Strokes) 01/2018 - 07/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 01/2012
4	Glioblastoma (Glioblastoma Multiforme) 01/2008 - 11/2006

Drug/Important Bio-Agent (IBA)

59	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2007
50	MicroRNAs (MicroRNA)IBA 08/2022 - 11/2008
44	Biomarkers (Surrogate Marker)IBA 06/2022 - 10/2010
27	Biological ProductsIBA 01/2022 - 05/2007
16	Long Noncoding RNAIBA 01/2022 - 01/2018
15	RNA (Ribonucleic Acid)IBA 12/2021 - 10/2010
14	Messenger RNA (mRNA)IBA 01/2022 - 06/2007
14	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2007
12	Pharmaceutical PreparationsIBA 01/2022 - 04/2007
12	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 09/2007
11	Transcription Factors (Transcription Factor)IBA 08/2022 - 02/2012
11	Peptides (Polypeptides)IBA 05/2022 - 01/2013
11	Cadherins (E-Cadherin)IBA 01/2021 - 01/2010
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2020 - 01/2006
9	LipidsIBA 01/2022 - 02/2011
8	CytokinesIBA 02/2021 - 01/2008
8	Phosphotransferases (Kinase)IBA 11/2020 - 09/2010
6	Circular RNAIBA 01/2022 - 01/2019
6	AntigensIBA 01/2021 - 08/2015
6	Carbapenems (Carbapenem Antibiotics)IBA 12/2020 - 01/2018
6	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2014
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 06/2017
5	AcidsIBA 04/2022 - 10/2005
5	EnzymesIBA 01/2022 - 02/2003
5	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 09/2012
5	Insulin (Novolin)FDA Link 01/2020 - 09/2007
5	NF-kappa B (NF-kB)IBA 01/2019 - 08/2006
5	baicaleinIBA 02/2018 - 04/2009
4	Carrier Proteins (Binding Protein)IBA 06/2022 - 03/2008
4	Indicators and Reagents (Reagents)IBA 05/2022 - 10/2010
4	ChitosanIBA 04/2022 - 07/2015
4	ChromatinIBA 01/2021 - 02/2013
4	Particulate MatterIBA 01/2021 - 10/2017
4	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 02/2010
4	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2020 - 01/2010
4	CateninsIBA 01/2020 - 04/2014
4	VimentinIBA 01/2020 - 01/2010
4	ProteomeIBA 10/2019 - 09/2012
4	Acid Sensing Ion ChannelsIBA 01/2019 - 10/2015
4	Fluorouracil (Carac)FDA LinkGeneric 02/2018 - 01/2014
4	Caveolin 1IBA 01/2018 - 02/2012
3	Cyclin D1IBA 06/2022 - 04/2010

Therapy/Procedure

46	Therapeutics 05/2022 - 04/2007
13	Drug Therapy (Chemotherapy) 01/2022 - 07/2010
7	Radiotherapy 01/2022 - 07/2010
7	Continuous Renal Replacement Therapy 06/2020 - 08/2013
7	Lasers (Laser) 01/2019 - 05/2007
5	Peritoneal Dialysis 01/2021 - 01/2014